0 Comments
0 Shares
133 Views
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
(R)-Nipecotic Acid Ethyl Ester Market Size & Forecast 2034 | Chiral Pharmaceutical Intermediate for CNS Drugs, GABA Uptake Inhibitors & Neurological TherapeuticsGlobal (R)-Nipecotic acid ethyl ester market was valued at USD 18.6 million in 2025 and is projected to reach USD 34.2 million by 2034, exhibiting a remarkable CAGR of 7.1% during the forecast period. (R)-Nipecotic acid ethyl ester is a specialized chiral pharmaceutical intermediate derived from nipecotic acid, valued for its role as a selective GABA uptake inhibitor. It has transitioned...0 Comments 0 Shares 106 Views
-
Benzodiazepine Drugs Market Innovations in CNS Therapeutics and Drug DevelopmentThe rising burden of mental health conditions and sleep-related disorders has significantly increased global demand for effective therapeutic solutions. Among the most widely used pharmacological options are anti-anxiety medications, anxiety disorder treatment, and insomnia treatment drugs, which play a crucial role in managing acute and chronic symptoms. These therapies are closely associated...0 Comments 0 Shares 161 Views
-
Central Nervous System (CNS) Therapeutics Market Size, Share, Growth Factors and Forecast 2026-2034According to IMARC Group, the global central nervous system (CNS) therapeutics market size reached USD 157.0 Billion in 2025 and is projected to reach USD 261.0 Billion by 2034, expanding at a CAGR of 5.58% during 2026–2034. This sustained Central Nervous System (CNS) Therapeutics Market Growth reflects the rising prevalence of neurological and psychiatric disorders, the expansion of...0 Comments 0 Shares 11 Views
-
Central Nervous System (CNS) Therapeutics Market Size, Share, Latest Insights and Forecast 2026-2034According to IMARC Group, the global Central Nervous System (CNS) Therapeutics Market Size reached USD 157.0 Billion in 2025 and is projected to reach USD 261.0 Billion by 2034, expanding at a CAGR of 5.58% during 2026–2034. This sustained Central Nervous System (CNS) Therapeutics Market Growth reflects the rising prevalence of neurological and psychiatric disorders, the expansion of...0 Comments 0 Shares 67 Views
-
Global Stress Management Drug Market Expands as Demand Rises for Innovative Mental Wellness and Stress TherapiesAccording to the latest report published by Data Bridge Market Research, the Stress Management Drug Market CAGR Value An international Stress Management Drug Market report can be employed by market players to learn about the competitive landscape and the level of competition in the global market. This market survey report includes a comprehensive evaluation of the...0 Comments 0 Shares 141 Views
Bangla